SHANGHAI, February, 2014 – The Global Pharma Congress 2014 will be organized in Shanghai on 28-29th of May 2014, by UBM China and CPhI Conferences. It is designed to be an insightful and valuable event highlighting the innovations, research and evolution in the Pharmaceutical industry. This summit will integrate CPhI Global Resources and display 3 influential conferences under one roof.
Quality by Design (QbD) has been the consensus of pharmaceutical industry. Due to increased export of Active Product Ingredients and formulations, it is necessary for pharmacy to master the methodology of QbD. Also, challenges from new Good Supply Practices by China Food & Drugs Administration (CFDA) and EU GDP influence the whole pharmacy supply/cold chain and drug distribution. At present, coverage of pharma cold-chain has reached 10% in China and nearly 20% drug quality problems are related to it, cold chain technology improvement is very urgent. Moreover, the stakeholders will also discuss how to realize product differentiation and enhance the level of research & commercialization by making use of the latest DDS and formulation strategy. This has become an urgent challenge for pharmacy. Application of new technology like sustained/controlled release, nanoparticles and new material implantation is also inspiring the industry.
Due to the success of 2 annual events on Pharma QbD, 4 annual events on Pharma Supply Chain, 4 annual events on Pharma Cold Chain and 4 annual events on NDDS, CPhI Conferences will now utilize the experience of these pharmaceutical events to conduct an outstanding Global Pharma Congress. This event will create a bridge between the different departments/functions of drug manufacturing. It is a good opportunity to accelerate progress in the pharmaceutical industry and promote coordination and communications for higher industrial progress and interaction.